 |
Kekst & Co is handling Avista Capital Markets private equity firm's merger of a "blank check company" with Organogenesis Inc. advanced wound care and sports medicine operation.
ACM has agreed to invest $92M in Canton, MA-based Organogenesis, which is expected to trade on the NASDAQ with an enterprise value in the $675M range when the deal closes by the end of the year.
Organogenesis has more than 600 employees involved in the development, manufacture and commercialization of products in the regenerative medicine sector.
Tom Dean, CEO of Avista Healthcare Public Acquisition Corp., said Organogenesis is "well-positioned to benefit from secular tailwinds driving the advance would care, surgical and sports medicine sectors."
Kekst's Daniel Yunger reps Avista and AHPAC.
Prosek Partners handles New York’s Tilray Brands, craft beer & cannabis operation, as it acquires BrewDog, a leading British independent beer producer in the UK, for $45M.
Brunswick Group handles Zurich Insurance as it agrees to buy UK-based Beazley specialty insurer in a deal valued at $11B.
FGS Global represents Brink’s as it agrees to acquire NCR Atleos, which relies on Collected Strategies, in a $6.6B cash & stock deal to create a leading fintech infrastructure company. (Updated)
A January article in O’Dwyer’s proposes that in 2026, the strongest financial brands will not simply tell compelling stories—they will “signal readiness.”
C Street Advisory Group is working the Chapter 11 filing of Axip Energy Services as it unloads its nearly all of its assets to deal with a heavy debt load.
